ArticleOncogene2013

Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.

V Chell et al.PubMed ↗Publisher ↗

No numbers read from the abstract.